INS and colorectal carcinoma: Proposed mechanisms include elevated glucose and insulin levels, adipokines, chemokines, and immune function changes.[4] Considering the shared risk factors of both conditions and the heightened risk of CRC in individuals with T2DM, it would be reasonable and of great interest to explore the potential of conventional type 2 diabetes therapies as an avenue for CRC prevention.